8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
An expert overview of the literature, useful as background reading.
2016 / Historical review
This review evaluated the history of obesity treatment from ancient times to the present day using literature searches in PubMed and ClinicalTrials.gov. The authors note that early anti-obesity recommendations focusing on diet, exercise, lifestyle, and emetics originated with Hippocrates and remained mostly unchanged until the early 20th century. Following mid-20th-century amphetamine-based drugs and later regulatory reductions by the 1990s, several new therapies have been approved or are currently in development for long-term treatment.
Haslam D Int J Clin Pract, 2016. PMID 26811245
2016 / Narrative review
This review summarizes modern approaches to obesity management. Foundational to weight loss efforts are lifestyle change, an adhereable high-quality diet, and at least 150 minutes of moderate weekly physical activity. For patients needing additional support, approved medications (such as orlistat, naltrexone/bupropion, liraglutide, lorcaserin, and phentermine/topiramate) and surgical management can improve health and reduce mortality in severe obesity.
Bray GA, Frühbeck G, Ryan DH, et al. Lancet, 2016. PMID 26868660
2016 / Systematic review of intervention trials
This systematic review analyzed 22 articles reporting on 19 intervention trials focused mostly on weight loss or weight gain prevention. Most interventions combined self-weighing with other self-monitoring strategies (64%), utilized daily self-weighing (84%), and lasted up to six months (59%). Improved weight outcomes were demonstrated in 75% of self-weighing-only interventions and 67% of combined interventions that reported efficacy data. No negative psychological effects were observed.
Shieh C, Knisely MR, Clark D, et al. Obes Res Clin Pract, 2016. PMID 26896865
2016 / Narrative review
This review describes cancer cachexia as a systemic metabolic syndrome wherein tumor growth is supported by tissue wasting and metabolite mobilization. Cachexia causes unstoppable loss of skeletal muscle and fat storage despite adequate caloric intake, leading to nutrient mobilization directly as lipids and amino acids and indirectly as glucose from liver gluconeogenesis. Metabolic dysfunctions include increased insulin and IGF-1 resistance, mitochondrial uncoupling, and fat browning, and cachexia is estimated to be the direct cause of at least 20% of cancer deaths.
Porporato PE Oncogenesis, 2016. PMID 26900952
2016 / Policy review and proposal
This article discusses how point-of-purchase marketing practices interfere with consumers' ability to eat healthy diets, often working through non-cognitive processes. The authors describe four point-of-purchase policy options: standardized portion sizes, standards for bundled meals (such as 'combo meals'), placement and marketing restrictions on highly processed low-nutrient foods, and explicit warning labels. The authors argue that adopting these policies could significantly contribute to preventing obesity and chronic diseases, noting that many can be implemented locally while preserving consumer choice.
Cohen DA, Lesser LI Obes Rev, 2016. PMID 26910361
2016 / Narrative review essay
This essay reviewed the evidence regarding the effectiveness of various antiobesity programs and policies. While some initiatives showed negligible effects, others demonstrated small beneficial impacts on diet, physical activity, and weight. Key findings noted that nutrition and calorie labels led to healthful food reformulations, incentives shifted behaviors in children and adults, and select school-based interventions proved cost-effective. Precommitment mechanisms and bariatric surgery were associated with weight loss, though they may not suit the majority of individuals with obesity.
Cawley J J Health Polit Policy Law, 2016. PMID 26921381
2016 / Editorial / Narrative review
This review examines placebo-related factors (PRFs) and how they may affect outcomes usually attributed to diet and lifestyle interventions in obesity settings. Research participants assigned to placebo-control conditions frequently report improved outcomes and can display physiologic responses resembling those receiving bioactive compounds, even when aware of receiving a placebo. The authors consider environmental and psychosocial influences, including information disclosure, expectations, conditioning, and empathy, and offer suggestions for enhancing PRFs in clinical obesity management.
Fontaine KR, Williams MS, Hoenemeyer TW, et al. Obesity (Silver Spring), 2016. PMID 27028278
2016 / Narrative review
This review examines the obesity-hypertension phenotype, noting that global rates of overweight and obesity have substantially increased. Findings indicate that an increased risk for hypertension is clearly linked to obesity through obesity-induced pathophysiologic adaptations. Primordial prevention focused on lifelong healthy lifestyle patterns is recommended, while treatment requires aggressive focus on weight loss and blood pressure control.
Arena R, Daugherty J, Bond S, et al. Curr Opin Cardiol, 2016. PMID 27070650
2016 / Narrative review
This review evaluates current and emerging endoscopic bariatric therapies for obesity and associated cardio-metabolic comorbidities. Currently, two intragastric balloons have FDA approval for 6-month implantation in patients with a BMI of 30-40 kg/m². Additionally, full-thickness suturing has enabled primary endoscopic sleeve gastroplasty and Roux-en-Y gastric bypass revision as viable alternatives to surgery.
Goyal D, Watson RR Curr Gastroenterol Rep, 2016. PMID 27098813
2016 / Narrative review
This review examined the relationship between obesity and lower limb osteoarthritis (OA). A proven association exists between obesity and knee OA, with obese patients (BMI > 30 kg/m^2) more likely to require total knee arthroplasty (TKA). Evidence suggests obese patients face higher rates of short- to medium-term complications following TKA—such as wound infection, medical complications, and potentially early revision—but they can still benefit through improved function, quality of life, and satisfaction.
Shows an association, not proof of cause and effect.
Kulkarni K, Karssiens T, Kumar V, et al. Maturitas, 2016. PMID 27180156
2016 / Narrative review of intervention-based literature
This review evaluated intervention-based studies examining the effects of breakfast consumption, composition, and size on weight management markers and daily food intake. Overall, limited intervention evidence supports or refutes daily breakfast consumption for these outcomes, though evidence is accumulating for higher protein, fiber, and morning energy. However, most trials manipulating breakfast composition failed to control for habitual breakfast patterns or include a breakfast-skipping control group, leaving causal roles unclear.
Leidy HJ, Gwin JA, Roenfeldt CA, et al. Adv Nutr, 2016. PMID 27184285
2016 / Narrative review
This review summarizes the natural history and progression of non-alcoholic fatty liver disease (NAFLD). NAFLD ranges from bland steatosis to non-alcoholic steatohepatitis (NASH), with emerging data indicating that fibrosis is the most important histological predictor of liver- and non-liver-related death. Metabolic syndrome and its components play a key role in the histological progression of NAFLD, while hepatocellular carcinoma in non-cirrhotic liver is associated with metabolic syndrome and male gender. Beyond liver-related outcomes, cardiovascular disease and malignancy represent major causes of death in individuals with NAFLD.
Shows an association, not proof of cause and effect.
Calzadilla Bertot L, Adams LA Int J Mol Sci, 2016. PMID 27213358
2016 / Narrative review
This narrative review examined eight sets of dietary studies, comparing findings between randomised controlled trials (RCTs) and epidemiological studies (mostly cohort studies) covering blood pressure, body weight, cancer, and heart disease. While some study findings were consistent, others conflicted. The review noted that RCTs frequently enroll high-risk participants or those with disease history and follow them for only weeks or months, whereas cohort studies typically follow healthy subjects for 5 to 15 years. Consequently, RCT findings are not necessarily more reliable than well-designed prospective cohort studies.
Temple NJ Br J Nutr, 2016. PMID 27267302
2016 / Narrative review of randomized controlled trials
This review summarizes findings from the Bath Breakfast Project exploring morning fasting versus breakfast in lean and obese adults. Current evidence does not support a clear effect of consuming or skipping breakfast on body mass/composition, metabolic rate, or diet-induced thermogenesis. Daily energy intake was either unaffected or slightly lower when omitting breakfast due to compensatory feeding later in the day. However, both lean and obese adults expended less energy during the morning when remaining fasted compared to when consuming a prescribed breakfast, indicating compensatory adjustments in physical activity thermogenesis.
Betts JA, Chowdhury EA, Gonzalez JT, et al. Proc Nutr Soc, 2016. PMID 27292940
2016 / Narrative review
This narrative review evaluated observational and intervention studies on irregular meal patterns and cardiometabolic consequences. Few observational studies were found, but most suggested eating meals irregularly is associated with a higher risk of metabolic syndrome and cardiometabolic risk factors such as BMI and blood pressure. Additionally, two randomized controlled trials found that consuming meals regularly for 2 weeks versus an irregular pattern led to lower peak insulin and lower fasting total and LDL-cholesterol in lean and obese women. The authors noted the evidence is limited and highlighted the need for more large-scale studies with detailed dietary assessments.
Pot GK, Almoosawi S, Stephen AM Proc Nutr Soc, 2016. PMID 27327128
2016 / Narrative review of observational studies
This review examined data from cross-sectional surveys and longitudinal cohorts on global trends in time-of-day of energy intake and its relationship with obesity. A wide variation in time-of-day energy distribution was observed across countries and regions. Across eight cross-sectional surveys and two longitudinal cohorts identified for obesity outcomes, associations between time-of-day of energy intake and obesity varied widely, with several studies reporting a positive link between evening energy intake and obesity.
Shows an association, not proof of cause and effect.
Almoosawi S, Vingeliene S, Karagounis LG, et al. Proc Nutr Soc, 2016. PMID 27327252
2016 / Narrative review
This review discusses the relationship between chronodisruption (CD), circadian rhythms, and obesity. While mutations in clock genes are rare in humans (<1% of the population), single nucleotide polymorphisms in clock genes are common and relate to obesity and weight loss. The authors highlight that nutrigenetics and epigenetics show behaviors can interact with genetic risk variants, proposing that modifying what, how, and when we eat can serve as an effective tool to diminish CD and decrease obesity.
Lopez-Minguez J, Gómez-Abellán P, Garaulet M Proc Nutr Soc, 2016. PMID 27339810
2016 / Narrative review
This review summarizes the functional properties of spinach (Spinacia oleracea L.) and its bioactives across cell culture, animal, and human studies. Spinach contains phytochemicals and bioactives, such as glycolipids and thylakoids, that scavenge reactive oxygen species, modulate genes involved in metabolism and inflammation, and curb food intake by inducing satiety hormones. These biological activities contribute to anti-cancer, anti-obesity, hypoglycemic, and hypolipidemic properties, though spinach consumption remains relatively low compared to other leafy greens.
Roberts JL, Moreau R Food Funct, 2016. PMID 27353735
2016 / Narrative review
This mini-review develops the hypothesis that increased hydration promotes body weight loss, primarily through decreased feeding and fat loss via increased lipolysis. The hypothesis is built on animal studies linking renin-angiotensin system manipulations to increased drinking and reduced body weight, as well as an association between chronic hypohydration, elevated angiotensin II, and chronic diseases. Proposed mechanisms involve increased metabolism from hydration expanding cell volume. The author notes that human studies are consistent with this hypothesis for weight loss and reducing risk factors for obesity and type 2 diabetes.
Shows an association, not proof of cause and effect.
Thornton SN Front Nutr, 2016. PMID 27376070
2016 / Narrative review
This review discusses the role of diet and the gut microbiota in metabolic diseases such as obesity and type 2 diabetes. Findings from animal models and human studies indicate that the gut microbiota mediates dietary impacts on host metabolism. Current research is focusing on establishing causal relationships in humans and developing therapeutic interventions like personalized nutrition.
Sonnenburg JL, Bäckhed F Nature, 2016. PMID 27383980
2016 / Narrative review
Obesity affects 35% of US adults and increases the risk of many cancer types while being associated with poor outcomes. Clinical management of cancer patients currently remains largely identical between normal weight and obese individuals. This review summarizes literature exploring inflammation as a potential shared causal driver of cancer initiation and progression across different cancer types.
Kolb R, Sutterwala FS, Zhang W Curr Opin Pharmacol, 2016. PMID 27429211
2016 / Comprehensive narrative review
This review summarizes literature supporting the Canadian Diabetes Association's recommendation of plant-based diets (PBDs) for type 2 diabetes medical nutrition therapy. Large observational studies linked PBDs to a lower prevalence of type 2 diabetes. In intervention trials, PBDs were as effective or more effective than other diabetes diets for improving body weight, cardiovascular risk factors, insulin sensitivity, glycated hemoglobin, oxidative stress, and renovascular markers, while reducing the need for diabetes medications.
Rinaldi S, Campbell EE, Fournier J, et al. Can J Diabetes, 2016. PMID 27476051
2016 / Narrative review
This review provides an overview of the psychosocial burden associated with obesity and its comorbidities, which include cardiovascular disease, type 2 diabetes, sleep apnea, osteoarthritis, and cancer. It describes psychological changes commonly seen with weight loss, noting that evaluating psychosocial functioning is key to assessment and treatment planning. A particular focus is placed on psychosocial functioning in individuals with extreme obesity undergoing bariatric surgery.
Shows an association, not proof of cause and effect.
Sarwer DB, Polonsky HM Endocrinol Metab Clin North Am, 2016. PMID 27519139
2016 / Narrative review
This review evaluates the role of energy and nutrient timing in weight control. Observational studies on the topic are largely inconclusive due to methodological limitations. Experimental evidence does not support a causal role for eating frequency or breakfast skipping in weight control. However, emerging evidence suggests that eating irregularity and eating later in the day may be detrimental for weight control, though more studies are needed.
McCrory MA, Shaw AC, Lee JA Endocrinol Metab Clin North Am, 2016. PMID 27519140